Ginkgo Bioworks Holdings, Inc. (DNA) Financials
DNA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 1.0 billion | 589.9 million |
| Dec. 31, 2025 | 1.1 billion | 611.1 million |
| Sept. 30, 2025 | 1.2 billion | 629.4 million |
| June 30, 2025 | 1.2 billion | 618.1 million |
DNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -48.4 million | 15.9 million |
| Dec. 31, 2025 | -63.0 million | 21.0 million |
| Sept. 30, 2025 | -31.6 million | 17.8 million |
| June 30, 2025 | -40.3 million | 22.2 million |
DNA Net Income
No data available :(
DNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 373.5 million | 410.7 million | 410.7 million |
| Dec. 31, 2025 | 422.6 million | 417.1 million | 439.9 million |
| Sept. 30, 2025 | 461.9 million | 422.9 million | 422.9 million |
| June 30, 2025 | 473.7 million | - | 428.8 million |
DNA Shares Outstanding
DNA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 1.9 million | 49.9 million | 37.8 million | - |
| Dec. 31, 2025 | 15.3 million | 50.1 million | 46.0 million | - |
| Sept. 30, 2025 | 7.7 million | 69.4 million | 45.0 million | - |
| June 30, 2025 | 38000 | 53.4 million | 43.3 million | - |
DNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 19.5 million | 15.9 million |
| Dec. 31, 2025 | 33.4 million | -8.2 million |
| Sept. 30, 2025 | 38.8 million | 12.8 million |
| June 30, 2025 | 49.6 million | 14.8 million |
DNA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
DNA
Price: $8.24
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.38 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 21.0 million
Market Capitalization: 537.0 million